Landong, Reynaldo Jr. L.

HRN: 29-14-40  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/13/2026
CEFTRIAXONE 1G (VIAL)
06/13/2026
06/19/2026
IV
2gm
Q24h
Cap Mr
Remove - Pending Acceptance
06/13/2026
AZITHROMYCIN 500MG TABLET (TAB)
06/13/2026
06/17/2026
PO
500mgtab
Q24
Cap Mr
Remove - Pending Acceptance
06/19/2026
TENOFOVIR DISOPROXIL FUMARATE 300MG TAB
06/19/2026
07/31/2026
PO
300
OD
HIV
Remove - Pending Acceptance
06/19/2026
BENZATHINE BENZYLPENICILLIN 1.2M UNITS VIAL
06/19/2026
07/24/2026
IM
2.4
Once A Week
HIV
Remove - Pending Acceptance
06/19/2026
COTRIMOXAZOLE 960MG (TAB)
06/19/2026
06/26/2026
ORAL
2 Tabs
TID
Pneumonia In Immunocompromised
Remove - Pending Acceptance
06/21/2026
COTRIMOXAZOLE 960MG (TAB)
06/21/2026
07/11/2026
PO
160/800mg
TID
Pneumonia In Immunocompromised Host
Remove - Pending Acceptance
06/21/2026
CEFTAZIDIME 1GM (VIAL)
06/21/2026
06/28/2026
IV
2g
Q8
PCP
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: